Physician profile
David MD Banh
NPI 1972829331
$4,342.79
in general payments reported to CMS, 2019-2025
16 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $3,438 · 2024: $319 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Education: $1,500 · Travel and Lodging: $709 · Consulting Fee: $350 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.58 |
| Education | $1,500.00 |
| Travel and Lodging | $708.51 |
| Consulting Fee | $350.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,900.93 | 2022-2023 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Meditrina | $543.12 | 2023-2025 | |
| Medtronic, INC. | $251.72 | 2023-2025 | Ligasure |
| Ethicon US, LLC | $144.93 | 2022-2024 | Vistaseal, Ethicon, Stratafix |
| Baxter Healthcare | $134.57 | 2025 | Floseal |
| Organon LLC | $55.13 | 2023-2024 | Nexplanon |
| Astellas Pharma US INC | $53.78 | 2023-2024 | Veozah |
| Coopersurgical, INC. | $45.78 | 2023-2024 | Endosee |
| Evofem Biosciences, INC. | $44.49 | 2022-2024 | |
| Octapharma USA, INC. | $35.94 | 2025 | Fibryga |
| Integra Lifesciences Corporation | $32.04 | 2023 | Medihoney, Biofix, Biodoptix |
| Pfizer INC. | $28.65 | 2025 | |
| Abbvie INC. | $23.99 | 2022 | |
| Myovant Sciences INC. | $20.69 | 2022 | |
| Kci USA, INC. | $16.13 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $10.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Banh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.